D011897ProceduresE05.318.780.700E05.581.500.805N05.715.360.780.675N06.850.520.445.700880.998373Random Allocationcmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.06544240.007992338research area of0.2142160.022643615subject area for28350251Chaudhry M, Alessandrini M, Rademan J, Dodgen TM, Steffens FE, van Zyl DG, Gaedigk A, Pepper MSPharmacogenomicsChaudhry M, Alessandrini M, Rademan J, Dodgen TM, Steffens FE, van Zyl DG, Gaedigk A, Pepper MS. Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study. Pharmacogenomics. 2017 Apr; 18(5):433-443.Pharmacogenomics2017-03-28T00:00:002017Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.PhDDelwynCatleyDelwyn Catley0.000000000000000.0000000000000067Catley, Delwyn0000-0002-7270-8732Associate Director, Center for Children's Healthy Lifestyles & Nutrition2Associate Professor1Professor11644992Lantos JDPaediatric and perinatal epidemiologyLantos JD. Was the UK collaborative ECMO trial ethical? Paediatr Perinat Epidemiol. 1997 Jul; 11(3):264-8.Paediatr Perinat Epidemiol1997-07-01T00:00:001997Was the UK collaborative ECMO trial ethical?PhDElinGrundbergElin Grundberg0.000000000000000.00000000000000138Grundberg, Elin0000-0001-5415-7896Roberta D. Harding & William F. Bradley Jr. Endowed Chair in Genomic Research PediatricsResearchClinicalPhD, MSAndreaGaedigkAndrea Gaedigk39.08346750000000-94.577112900000001Gaedigk, Andrea0000-0001-6968-1893Director, Pharmacogenetics Core LaboratoryMD, PhDMarkClementsMark A. Clements39.08346750000000-94.5771129000000023Clements, MarkEndocrinologist and Medical Director, Pediatric Clinical Research UnitChildren's Mercy Kansas CityMD, MSRobertLaneRobert H. Lane0.000000000000000.00000000000000179Lane, RobertExecutive Vice President/Physician-in-Chief32333646Ke X, Fu Q, Sterrett J, Hillard CJ, Lane RH, Majnik APhysiological reportsKe X, Fu Q, Sterrett J, Hillard CJ, Lane RH, Majnik A. Adverse maternal environment and western diet impairs cognitive function and alters hippocampal glucocorticoid receptor promoter methylation in male mice. Physiol Rep. 2020 04; 8(8):e14407.Physiol Rep2020-04-01T00:00:002020Adverse maternal environment and western diet impairs cognitive function and alters hippocampal glucocorticoid receptor promoter methylation in male mice.34391509Nordstr?m T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, J?derling F, Eklund M, Gr?nberg HThe Lancet. OncologyNordstr?m T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, J?derling F, Eklund M, Gr?nberg H. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. Lancet Oncol. 2021 09; 22(9):1240-1249.Lancet Oncol2021-08-13T00:00:002021Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.35435813Faseru B, Mussulman LM, Nazir N, Ellerbeck EF, Shergina E, Scheuermann TS, Gajewski BJ, Catley D, Richter KPSubstance abuseFaseru B, Mussulman LM, Nazir N, Ellerbeck EF, Shergina E, Scheuermann TS, Gajewski BJ, Catley D, Richter KP. Use of pre-enrollment randomization and delayed consent to maximize participation in a clinical trial of opt-in versus opt-out tobacco treatment. Subst Abus. 2022; 43(1):1035-1042.Subst Abus2022-01-01T00:00:002022Use of pre-enrollment randomization and delayed consent to maximize participation in a clinical trial of opt-in versus opt-out tobacco treatment.true1Director, Pharmacogenetics Core LaboratoryDirector, Pharmacogenetics Core Laboratorytrue1Associate Director, Center for Children's Healthy Lifestyles & NutritionAssociate Director, Center for Children's Healthy Lifestyles & Nutritiontrue1Roberta D. Harding & William F. Bradley Jr. Endowed Chair in Genomic Research Roberta D. Harding & William F. Bradley Jr. Endowed Chair in Genomic Research true1Endocrinologist and Medical Director, Pediatric Clinical Research UnitEndocrinologist and Medical Director, Pediatric Clinical Research Unittrue1Executive Vice President/Physician-in-ChiefExecutive Vice President/Physician-in-Chief